fashion -WSS

fashion

author：explore 2025-09-09 19:30:59 - browse：92

-- health tech coverage from STAT — Courtesy Xaia/Cedars-Sinai

Apple Vision Pro, the company’s most important new product in a decade, promises to envelop consumers in an immersive world of interactive content while employing clever technologies to make the device more usable and less alienating than virtual reality headsets that have come before it.

Marketing for Vision Pro has focused on the $3,499, 1.3-pound helmet’s potential for watching video, making work calls, viewing family photos, and other casual uses. But as with its other devices, Apple is eager to explore Vision Pro’s health potential as well. The company connected STAT with researchers from Cedars-Sinai and Boston Children’s Hospital who have developed applications that transform the headset into an AI powered chatbot that offers otherworldly therapy sessions or a virtual guide that can train nurses by simulating the chaos of a busy hospital.

VRx Health, founded by researchers from Cedars-Sinai in Los Angeles, is today launching Xaia, a mental health chatbot app that uses an artificial intelligence model to generate human-like responses to users’ statements. A therapeutic chatbot isn’t a new idea, but Xaia takes advantage of Vision Pro’s ability to convincingly blend digital content with an image of the world around users.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

leisure time

WSS

Ascension's ugly legal battle over care for poor patients in Texas

Websites selling Wegovy, Zepbound ingredients targeted by FDA

STAT Virtual Event: JPM Recap, Live!

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Abbott's new heart device gets FDA advisory panel nod

American taxpayers paid $1.8 trillion in health care costs in 2022

hotspot

fashion

focus

Duchenne breakthrough therapy leaves behind pioneering families

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

In age of alternative facts, a scholarly course on calling out crap

Fauci's latest grilling in Congress: 9 hours, behind closed doors

How one medical school became remarkably diverse

AMAs digital advisors table RPM coding reform proposal, again

Jerome Adams on the need for new antivirals for Covid

Congress must protect the remaining independent doctors

Walensky prepares to leave CDC — and Congress — behind

Study gives hint on South Asians’ higher risk of cardiovascular disease

focus

Latigo launches with $135 million for Vertex

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Merck to acquire Harpoon Therapeutics for $680 million

STAT Boddities: What happens to the brain when we get scared?

Latigo launches with $135 million for Vertex

Artificial intelligence use in health care faces greater scrutiny in 2024

knowledge

leisure time

entertainment

Wikipedia